English  |  正體中文  |  简体中文  |  总笔数 :2853535  
造访人次 :  45243268    在线人数 :  995
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"su t h"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 1-50 / 608 (共13页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2022-09-16T03:41:20Z Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling Hung C.-T.; Su T.-H.; Chen Y.-T.; Wu Y.-F.; Chen Y.-T.; SUNG-JAN LIN; Lin S.-L.; Yang K.-C.
臺大學術典藏 2022-09-15T05:42:25Z Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; CHIEN-CHING HUNG; Kao J.-H.
臺大學術典藏 2022-09-09T04:21:43Z Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen–Negative Patients: An Asian Perspective Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:41Z Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease Huang S.-C.; Su H.-J.; JIA-HORNG KAO; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; Liu C.-J.
臺大學術典藏 2022-09-09T04:21:40Z Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters Lin S.-R.; Yang T.-Y.; Peng C.-Y.; Lin Y.-Y.; Dai C.-Y.; Wang H.-Y.; Su T.-H.; Tseng T.-C.; Liu I.-J.; Cheng H.-R.; Shen Y.-C.; Wu F.-Y.; Liu C.-J.; Chen D.-S.; Chen P.-J.; Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:39Z Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:38Z Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:32Z Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7) Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:27Z Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment Liu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:25Z Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study Papatheodoridi M.; Su T.-H.; Hadziyannis E.; Liao C.-H.; Orfanidou Α.; Yang H.-C.; Zachou K.; Liu C.-J.; Kourikou A.; Gatselis N.; Manolakopoulos S.; Dalekos G.; JIA-HORNG KAO; Hadziyannis S.; Papatheodoridis G.V.
臺大學術典藏 2022-09-09T04:21:22Z Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents Huang S.-C.; Cheng P.-N.; Liu C.-H.; Yang H.-C.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏 2022-09-09T04:21:21Z Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients with Indeterminate Phase Tseng T.-C.; Hosaka T.; Liu C.-J.; Suzuki F.; Hong C.-M.; Kumada H.; Yang W.-T.; Hsu C.-Y.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen H.-H.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:20Z Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities Hsu Y.-C.; Tseng C.-H.; Su T.-H.; JIA-HORNG KAO; Nguyen M.H.
臺大學術典藏 2022-09-09T04:21:19Z Paradigm shift in the treatment options of hepatocellular carcinoma Su T.-H.; Hsu S.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:18Z Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma Wang S.-Y.; Su T.-H.; Chen B.-B.; Liu C.-J.; Liu C.-H.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:16Z Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO
臺大學術典藏 2022-06-27T07:07:51Z Unusual dyspnoea in a patient with liver cirrhosis Su T.-H.; Liu W.-L.; CHONG-JEN YU; Huang G.-T.
臺大學術典藏 2022-04-25T07:36:12Z Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era Cheng C.-L.; Huang S.-C.; Chen J.-H.; Wei C.-H.; Fang W.-Q.; Su T.-H.; Yuan C.-T.; JIA-HAU LIU; Chuang M.-K.; Tien H.-F.
臺大學術典藏 2022-04-21T06:50:07Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen, Tony Hsiu Hsi; Chen P.-J.; Kao J.-H.
臺大學術典藏 2022-04-01T08:53:00Z Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice Lin W.-H.; Yeh S.-H.; Yeh K.-H.; Chen K.-W.; YAWEN CHENG; Su T.-H.; Jao P.; Ni L.-C.; Chen P.-J.; Chen D.-S.
臺大學術典藏 2022-03-22T08:28:25Z On the decrease in transformation stress in a bicrystal cu-al-mn shape-memory alloy during cyclic compressive deformation Su T.-H;Lu N.-H;Chen C.-H;Chen C.-S.; Su T.-H; Lu N.-H; Chen C.-H; Chen C.-S.; CHIH-HSUAN CHEN
臺大學術典藏 2022-03-22T08:28:25Z On the decrease in transformation stress in a bicrystal cu-al-mn shape-memory alloy during cyclic compressive deformation Su T.-H;Lu N.-H;Chen C.-H;Chen C.-S.; Su T.-H; Lu N.-H; Chen C.-H; Chen C.-S.; CHIH-HSUAN CHEN
臺大學術典藏 2022-03-22T08:27:47Z On the decrease in transformation stress in a bicrystal cu-al-mn shape-memory alloy during cyclic compressive deformation Su T.-H;Lu N.-H;Chen C.-H;Chen C.-S.; Su T.-H; Lu N.-H; Chen C.-H; Chen C.-S.; CHUIN-SHAN CHEN
臺大學術典藏 2022-03-22T08:27:47Z On the decrease in transformation stress in a bicrystal cu-al-mn shape-memory alloy during cyclic compressive deformation Su T.-H;Lu N.-H;Chen C.-H;Chen C.-S.; Su T.-H; Lu N.-H; Chen C.-H; Chen C.-S.; CHUIN-SHAN CHEN
臺大學術典藏 2022-03-22T08:25:40Z On the decrease in transformation stress in a bicrystal cu-al-mn shape-memory alloy during cyclic compressive deformation Su T.-H;Lu N.-H;Chen C.-H;Chen C.-S.; Su T.-H; Lu N.-H; Chen C.-H; Chen C.-S.; CHIH-HSUAN CHEN
臺大學術典藏 2022-03-22T08:25:04Z On the decrease in transformation stress in a bicrystal cu-al-mn shape-memory alloy during cyclic compressive deformation Su T.-H;Lu N.-H;Chen C.-H;Chen C.-S.; Su T.-H; Lu N.-H; Chen C.-H; Chen C.-S.; CHUIN-SHAN CHEN
臺大學術典藏 2022-03-10T05:59:36Z Prostaglandin reductase-3 negatively modulates adipogenesis through regulation of PPARγ activity Yu Y.-H.; YI-CHENG CHANG; Su T.-H.; Nong J.-Y.; Li C.-C.; Chuang L.-M.
臺大學術典藏 2022-03-04T06:55:01Z Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma SIH-HAN LIAO; Su T.-H.; Jeng Y.-M.; Liang P.-C.; Chen D.-S.; Chen C.-H.; Kao J.-H.
臺大學術典藏 2022-03-04T06:55:01Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.; SIH-HAN LIAO; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏 2022-03-04T06:55:00Z Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma Huang S.-C.; SIH-HAN LIAO; Su T.-H.; Jeng Y.-M.; Kao J.-H.
臺大學術典藏 2022-02-23T02:12:23Z Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma Liao S.-H.; Su T.-H.; Jeng Y.-M.; Liang P.-C.; Chen D.-S.; CHIEN-HUNG CHEN; Kao J.-H.
臺大學術典藏 2022-02-22T05:34:13Z Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma Liao S.-H.; Su T.-H.; Jeng Y.-M.; Liang P.-C.; Chen D.-S.; CHIEN-HUNG CHEN; Kao J.-H.
臺大學術典藏 2022-02-14T06:28:49Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H.; Liu C.-J.; Su T.-H.; YU-JEN FANG; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-02-14T06:28:46Z Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; YU-JEN FANG; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-02-14T06:28:43Z Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis Liu C.-H.; Peng C.-Y.; YU-JEN FANG; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:10:34Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B Su T.-H.; Hsu C.-S.; CHI-LING CHEN; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:10:33Z HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S.
臺大學術典藏 2022-01-25T05:07:26Z Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters Tseng T.-C.; Liu C.-J.; CHI-LING CHEN; Wang C.-C.; Su T.-H.; Kuo S.F.-T.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:07:26Z High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; CHI-LING CHEN; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:07:25Z Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; CHI-LING CHEN; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:07:24Z Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; CHI-LING CHEN; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:07:23Z Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; CHI-LING CHEN; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:07:23Z Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion Yang H.-C.; CHI-LING CHEN; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:07:22Z Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C Su T.-H.; Liu C.-H.; Liu C.-J.; CHI-LING CHEN; Ting T.-T.; Tseng T.-C.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2022-01-25T05:07:22Z Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection Su T.-H.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; CHI-LING CHEN; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2022-01-25T05:07:21Z Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers Tseng T.-C.; Liu C.-J.; CHI-LING CHEN; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:22Z Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters Tseng T.-C.; Liu C.-J.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:18Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C.; Liu C.-J.; CHI-LING CHEN; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:17Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C.; Liu C.-J.; Yang H.-C.; CHI-LING CHEN; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:15Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.; Wu L.-W.; Tseng T.-C.; CHI-LING CHEN; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.

显示项目 1-50 / 608 (共13页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目